MAR 16, 2020 9:43 PM PDT

Understanding How an Obesity-Treating Drug Functions

WRITTEN BY: Nouran Amin

Liraglutide is a drug targeted to help treat obesity by suppressing appetite, thus making the patient lose weight. However, up until now research has not determined the exact mechanisms of how this works.

"The goal is to produce even more weight loss treatments," said senior author Matthew R. Hayes, PhD, an associate professor of Psychiatry at Penn. "And this work takes us closer to fully realizing a better treatment strategy for obesity."

Learn more about obesity:

Now, a preclinical study done by the Perelman School of Medicine at the University of Pennsylvania and published in Science Translational Medicine indicates that liraglutide crosses the brain's blood barrier and engaging with the region of the brainstem known as the nucleus tractus solitarius (NTS). It was found that NTS balances food intake and energy expenditure.

"This discovery opens up the door for future obesity drug treatments that could be used in conjunction with this FDA-approved therapy to treat obesity," says Hayes. "The more we understand how drugs act, the more we can understand what other brain systems can be manipulated in combination with them to help patients lose more weight."

Liraglutide interacts with glucagon-like peptide-1 receptors (GLP-1R) on GABA neurons (specific form of brain cells) that suppress hunger.

"We've narrowed in on the NTS to more fully understand how this site in the brain is critically important for body weight regulation," said first author Samantha M. Fortin, PhD, a postdoctoral research fellow in Hayes' lab. "Our finding that GABA neurons in the NTS are important for the anorectic effects of liraglutide may prove to be meaningful in the future. Other compounds or genetic manipulations that would target this distinct population of cells in the brain could be useful in treating obesity."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 19, 2020
Drug Discovery & Development
MAY 19, 2020
COVID-19 Vaccine On Track for Late 2020
Moderna, a biotechnology company based in Massachusetts, has released information on its vaccine against COVID-19 from i ...
MAY 12, 2020
Drug Discovery & Development
MAY 12, 2020
Novel Drug Approved for Non-Small Cell Lung Cancer
The US Food and Drug Administration (FDA) recently approved a therapeutic for treating metastatic non-small cell lung ca ...
MAY 29, 2020
Genetics & Genomics
MAY 29, 2020
Advances in Our Understanding of Huntington's Disease
Huntington's disease (HD) is a fatal neurodegenerative disease caused by an expanded sequence in the huntingtin gene.
JUN 16, 2020
Microbiology
JUN 16, 2020
A Bacterial Compound Could Become a Treatment for Parasitic Infections
The World Health Organization has estimated that parasitic infections cause over 48 million cases of illness and 59,000 ...
JUN 22, 2020
Drug Discovery & Development
JUN 22, 2020
MDMA Has Long-Term Benefits Against PTSD
Researchers have shown that MDMA-assisted psychotherapy has therapeutic effects that last over a year in treating post-t ...
JUL 02, 2020
Drug Discovery & Development
JUL 02, 2020
Common Asthma Drug Could Treat Alzheimer's
Researchers from Lancaster University, England, have found that Salbutamol, a medication commonly used to treat asthma, ...
Loading Comments...